SREBF1 and fatty liver disease: Nuciferine (6) treatment essentially reversed the HFD-induced increase in hepatic protein levels of SREBP-1c and fatty acid synthase (FASN), suggesting that nuciferine could attenuate the development of HFD-induced hepatic steatosis (Guo et al., 2013).